Literature DB >> 7678212

Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor.

C M Silva1, M J Weber, M O Thorner.   

Abstract

To investigate the possibility that tyrosine phosphorylation of cellular proteins might play a role in GH receptor signaling, we have studied tyrosine phosphorylation induced by GH and by GH mutants in the human lymphocyte line IM-9, a homologous cell system which is known to respond to GH by increased proliferation. IM-9 cells were treated with physiological concentrations of recombinant human GH (rhGH). Protein lysates from these cells were then analyzed by polyacrylamide gel electrophoresis, transferred to nitrocellulose, and probed with an antibody specific for phosphotyrosine. rhGH stimulated the tyrosine phosphorylation of two proteins having M(r) of approximately 93,000 and 120,000. Tyrosine phosphorylation of these proteins was time and dose dependent. At 2 nM rhGH tyrosine phosphorylation of these two proteins was evident by 5 min, maximal at 15 min, and decreasing by 45 min of treatment. At doses of 10 and 100 nM rhGH, tyrosine phosphorylation was stimulated by 1 min of GH treatment. IM-9 cells were also treated with genetically engineered mutant forms of the GH protein. Previous biophysical analysis of these mutant GH proteins has shown that the GH protein contains two distinct binding sites which interact in a sequential manner with the extracellular domains of two distinct GH receptor molecules, thus forming a dimeric complex. By treating IM-9 cells with these same GH mutants and analyzing tyrosine phosphorylation, we found that tyrosine phosphorylation was inhibited under conditions which prevent receptor dimerization, thus providing evidence that formation of a dimeric GH:(GH receptor)2 complex may be important for intracellular signaling by the GH receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678212     DOI: 10.1210/endo.132.1.7678212

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Biologically inactive growth hormone caused by an amino acid substitution.

Authors:  Y Takahashi; H Shirono; O Arisaka; K Takahashi; T Yagi; J Koga; H Kaji; Y Okimura; H Abe; T Tanaka; K Chihara
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Growth hormone stimulates the secretion of insulin-like growth factor binding protein-2 (IGFBP-2) by monolayer cultures of sheep costal growth plate chondrocytes.

Authors:  V Borromeo; S Bramani; A T Holder; C Carter; C Secchi; J Beattie
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

Review 3.  Binding in the growth hormone receptor complex.

Authors:  J A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

4.  Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.

Authors:  D S Finbloom; E F Petricoin; R H Hackett; M David; G M Feldman; K Igarashi; E Fibach; M J Weber; M O Thorner; C M Silva
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

Review 5.  Growth hormone receptor modulators.

Authors:  Vita Birzniece; Akira Sata; Ken K Y Ho
Journal:  Rev Endocr Metab Disord       Date:  2009-06       Impact factor: 6.514

6.  Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.

Authors:  E Kilgour; I Gout; N G Anderson
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

7.  Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells.

Authors:  I Dusanter-Fourt; O Muller; A Ziemiecki; P Mayeux; B Drucker; J Djiane; A Wilks; A G Harpur; S Fischer; S Gisselbrecht
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.